An interim analysis from the REVEAL study provides insights into patient profiles and early responses in systemic lupus erythematosus patients initiating treatment with anifrolumab. This multicenter observational study aims to enhance understanding of treatment effects in this complex disease.
patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab interim analysis from the ongoing multicentre observational reveal study
Original title: “Patient profiles and early response in patients with systemic lupus erythematosus initiating anifrolumab: interim analysis from the ongoing multicentre observational REVEAL study.”